Thu, Nov 27, 2014, 1:11 AM EST - U.S. Markets closed for Thanksgiving Day

Recent

% | $
Quotes you view appear here for quick access.

Amarin Corporation plc Message Board

  • octaveus26 octaveus26 Oct 13, 2013 10:17 AM Flag

    Simvastatin and mineral oil

    No horse in this race, but I'm always drawn to names that are blown up to see if its warranted. I have gone through the FDA document to try to understand all the fuss. It appears to me that part of the issue with the reaction is the hypothesis of the FDA reviewer that the results are "overstated" because of the use of the mineral oil in the placebo arm. So if we start there, what the FDA reviewer is saying is that the mineral oil some how inhibits the uptake of the statin. So I've done of search of all the literature on Simvastatin (most used statin in the trial) and I have found NOTHING in the medical literature or databases that states there is any interaction between the statin and mineral oil. There is also nothing in the label of any of the statins warning that mineral oil intake inhibits the uptake of the statin. So I find it very curious that the reviewer can make this statement when there is no evidence of any interaction between the two. So the question is, why would the reviewer come to this conclusion that the benefits are "overstated" because of the mineral oil and statin in the placebo arm if there is no evidence that mineral oil has any interaction with the statin drug class? I don't get that one bit. Hopefully, the docs on the panel address this, because as is, the data is pretty impressive.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Not only this if you look at the wording I saw once instance
      where the reviewer talk about the effect of placebo she used the word
      HIGHLY statistic significant. Whereas for vascepa although result
      is highly stat sig in some area but reviewer did not put in the word 'highly'.
      Also reviewer seems like anticipating what amarin is going to bring
      in for discussion and shot down those 1st as a pre-em. Especially the
      jelis trial. The while bd imo is like drafted by serveral lawyers and
      doctors to counter whatever amarin are going to bring to the adcomm.

    • can you point me to where it says the simvastatin trials used mineral oil? you are talking about the COMBOS trial, right?

 
AMRN
1.26+0.040(+3.28%)Nov 26 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
The St. Joe Company
NYSEWed, Nov 26, 2014 4:06 PM EST
CIT Group Inc.
NYSEWed, Nov 26, 2014 4:00 PM EST